CAS: 1032754-93-0 - (S)-1-[4-[[2-(2-Aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one

Formel: C₂₃H₃₀N₈O₃S

InChl: InChI=1S/C23H30N8O3S/c1-14-17(13-29-3-5-31(6-4-29)22(33)15(2)32)35-19-18(14)27-20(16-11-25-23(24)26-12-16)28-21(19)30-7-9-34-10-8-30/h11-12,15,32H,3-10,13H2,1-2H3,(H2,24,25,26)/t15-/m0/s1

Synonyme:

• Gdc-0980
• Gne 390
• (S)-1-(4-((2-(2-aMinopyriMidin-5-yl)-7-Methyl-4-Morpholinothieno[3,2-d]pyriMidin-6-yl)Methyl)piperazin-1-yl)-2-hydroxypropan-1-one
• Gdc-0980 (Rg7422)
• Apitolisib
• (2S)-1-(4-{[2-(2-Amino-5-pyrimidinyl)-7-methyl-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl}-1-piperazinyl)-2-hydroxy-1-propanone

Apitolisib

CAS: 1032754-93-0

• Formel: C₂₃H₃₀N₈O₃S
• Reinheit: 98%
• Farbe und Form: Solid
• Molekulargewicht: 498.6011

Apitolisib

CAS: 1032754-93-0

Apitolisib (RG 7422) is a PI3K inhibitor, used in cancer trials, targeting PI3Kα, β, δ, …

• Formel: C₂₃H₃₀N₈O₃S
• Reinheit: 98.28% - 99.52%
• Farbe und Form: Solid
• Molekulargewicht: 498.6

RG7422

CAS: 1032754-93-0

GDC-0980

CAS: 1032754-93-0

Applications GDC-0980 is used in the synthesis of PI3K inhibitors to treat carcinomas. Potent PI3K/mTOR …

• Formel: C₂₃H₃₀N₈O₃S
• Farbe und Form: Neat
• Molekulargewicht: 498.6

(S)-1-(4-((2-(2-Aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one

CAS: 1032754-93-0

(S)-1-(4-((2-(2-Aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one is a CDK4/6 inhibitor that blocks the activity of these enzymes and inhibits cell …

• Formel: C₂₃H₃₀O₃N₈S
• Reinheit: Min. 95%
• Molekulargewicht: 498.6 g/mol